The FDA AI/ML Pipeline in 2026
The FDA has cleared over 700 AI-enabled medical devices, with radiology accounting for 60% of approvals. The interesting story is the shift in how AI is being integrated into clinical workflows.
Radiology: Where AI Has Definitively Arrived
AI-assisted radiologists catch more findings in less time than either radiologists or AI alone — validating the human-AI collaboration model over full automation.
"The paradigm shift isn't AI replacing radiologists — it's AI handling the routine so radiologists can focus on complex cases where human judgment is irreplaceable." — Dr. Marcus Webb, 2026
Pathology and Digital Slides
AI systems that grade prostate cancer (Gleason scoring) show inter-rater agreement with expert pathologists that exceeds human-to-human baseline agreement — a significant milestone.
Frequently Asked Questions
Has the FDA approved AI medical devices?
Yes. The FDA has cleared or approved over 700 AI/ML-enabled medical devices as of 2026, predominantly in radiology, cardiology ECG interpretation, and ophthalmology diabetic retinopathy screening.
Is AI used in clinical diagnosis?
AI-assisted diagnosis is used for imaging analysis, pathology, ECG interpretation, and sepsis prediction, typically as a decision-support tool alongside physicians.
What are the risks of AI in healthcare?
Key risks include algorithmic bias, overreliance on AI recommendations, data privacy concerns, and errors in high-stakes decisions. Regulatory oversight and clinical validation are essential safeguards.